Assessment and counseling for women with a family history of breast cancer. A guide for clinicians - PubMed (original) (raw)
. 1995 Feb 15;273(7):577-85.
Affiliations
- PMID: 7837392
Assessment and counseling for women with a family history of breast cancer. A guide for clinicians
K F Hoskins et al. JAMA. 1995.
Abstract
More women in all risk categories are seeking information regarding their individual breast cancer risk, and there is a need for their primary care clinicians to be able to assess familial risk factors for breast cancer, provide individualized risk information, and offer surveillance recommendations. Estimates of the number of women with a family history of breast cancer range from approximately 5% to 20%, depending on the population surveyed. Many of these women will not have a family history that suggests the presence of a highly penetrant breast cancer susceptibility gene. However, a small subset of such women will come from families with a striking incidence of breast and other cancers often associated with inherited mutations. The development and refinement of risk prediction models provide an epidemiologic basis for counseling women with a family history that does not appear related to a dominant susceptibility gene. contrast, the recent isolation of BRCA1, the localization of BRCA2, and the acknowledgement that additional breast cancer susceptibility genes must exist provide a molecular basis for counseling some high-risk women. We present a guide for primary care clinicians that may be helpful in defining families as moderate or high risk, in determining individual risk in women with a family history of breast cancer based on this distinction, and for counseling women in a setting where the data necessary to design surveillance and prevention strategies are lacking. We include criteria for selecting women who may be candidates for detection of inherited mutations in breast cancer susceptibility genes.
Similar articles
- [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J, Becher H, Hamann U, Schroeder-Kurth T. Chang-Claude J, et al. Zentralbl Gynakol. 1995;117(8):423-34. Zentralbl Gynakol. 1995. PMID: 7571905 German. - Factors associated with decisions about clinical BRCA1/2 testing.
Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B. Armstrong K, et al. Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11097234 - Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C. Burke W, et al. JAMA. 1997 Mar 26;277(12):997-1003. JAMA. 1997. PMID: 9091675 Review. - [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A. Chompret A. J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 12717301 Review. French.
Cited by
- Attitudes towards cancer predictive testing and transmission of information to the family.
Julian-Reynier C, Eisinger F, Vennin P, Chabal F, Aurran Y, Noguès C, Bignon YJ, Machelard-Roumagnac M, Maugard-Louboutin C, Serin D, Blanc B, Orsoni P, Sobol H. Julian-Reynier C, et al. J Med Genet. 1996 Sep;33(9):731-6. doi: 10.1136/jmg.33.9.731. J Med Genet. 1996. PMID: 8880571 Free PMC article. - Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G. Feng Y, et al. Genes Dis. 2018 May 12;5(2):77-106. doi: 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun. Genes Dis. 2018. PMID: 30258937 Free PMC article. Review. - Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients.
Barakeh DH, Aljelaify R, Bashawri Y, Almutairi A, Alqubaishi F, Alnamnakani M, Almubarak L, Al Naeem A, Almushawah F, Alrashed M, Abedalthagafi M. Barakeh DH, et al. Oncotarget. 2021 Mar 30;12(7):686-697. doi: 10.18632/oncotarget.27909. eCollection 2021 Mar 30. Oncotarget. 2021. PMID: 33868589 Free PMC article. - Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians.
Claus EB. Claus EB. Fam Cancer. 2001;1(3-4):197-206. doi: 10.1023/a:1021135807900. Fam Cancer. 2001. PMID: 14574179 Review. - Pilot study of an information aid for women with a family history of breast cancer.
Warner E, Goel V, Ondrusek N, Thiel EC, Lavina H, Lickley A, Chart PL, Meschino WS, Doan BD, Carroll JC, Taylor KM. Warner E, et al. Health Expect. 1999 May;2(2):118-128. doi: 10.1046/j.1369-6513.1999.00038.x. Health Expect. 1999. PMID: 11281885 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous